Shares of Canopy Growth Corporation (NASDAQ: CGC - Get Free Report) have received a consensus rating of "Reduce" from the five analysts that are covering the stock, MarketBeat.com reports. Two equitie
Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens gains in 2026 after a 16.39% rise in 2025, with AI leaders li
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.16, marking a -4.13% move from the previous day.
On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should ha

Do These 2 Cannabis Stocks Have a Future?

11:09pm, Sunday, 28'th Dec 2025
Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are two leaders in the Canadian market that could turn their attention
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te
President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana -- yet -- but it may foreshadow changes to come.

3 Marijuana Stocks To Watch In 2026

01:58pm, Friday, 26'th Dec 2025
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af

Marijuana Stocks To Watch After The Holidays

11:52am, Wednesday, 24'th Dec 2025
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi
VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- USA News Group - News Commentary - American consumers are driving record wellness spending as they abandon traditional cigarettes and sug
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories.
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE